New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
Covaxin is not approved in the USA for any age group
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
The first wave of shipments includes several countries, such as Germany, France and Austria
New biotechnology product aims to be world's fastest automatic sanitary solution
Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
_256_384.jpg)
Extending nonsurgical treatment options for Failing Pulmonic Valve in patients with congenital heart disease using Transcatheter Pulmonary Valve
Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training
The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily
Subscribe To Our Newsletter & Stay Updated
